Show simple item record

The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial

dc.contributor.authorNimmer, Mark
dc.contributor.authorCzachor, Jason
dc.contributor.authorTurner, Laura
dc.contributor.authorThomas, Bobbe
dc.contributor.authorWoodford, Ashley L.
dc.contributor.authorCarpenter, Karli
dc.contributor.authorGonzalez, Victor
dc.contributor.authorLiem, Robert I.
dc.contributor.authorEllison, Angela
dc.contributor.authorCasper, T. Charles
dc.contributor.authorBrousseau, David C.
dc.date.accessioned2016-09-17T23:55:08Z
dc.date.available2017-12-01T21:54:11Zen
dc.date.issued2016-09
dc.identifier.citationNimmer, Mark; Czachor, Jason; Turner, Laura; Thomas, Bobbe; Woodford, Ashley L.; Carpenter, Karli; Gonzalez, Victor; Liem, Robert I.; Ellison, Angela; Casper, T. Charles; Brousseau, David C. (2016). "The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial." Pediatric Blood & Cancer 63(9): 1649-1652.
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.urihttps://hdl.handle.net/2027.42/133619
dc.publisherWiley Periodicals, Inc.
dc.subject.othersickle cell disease
dc.subject.otherconsent
dc.subject.otherpreconsent, pediatric hematology/oncology
dc.titleThe Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133619/1/pbc26013.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133619/2/pbc26013_am.pdf
dc.identifier.doi10.1002/pbc.26013
dc.identifier.sourcePediatric Blood & Cancer
dc.identifier.citedreferenceSmithline HA, Mader TJ, Crenshaw BJ. Do Patients with acute medical conditions have the capacity to give informed consent for emergency medicine research? Acad Emerg Med 1999; 6: 776 – 780.
dc.identifier.citedreferenceZacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995; 3: 432 – 466.
dc.identifier.citedreferenceBrousseau DC, Scott JP, Badaki‐Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith‐Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, et al. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood 2015; 126: 1651 – 1657.
dc.identifier.citedreferenceBadaki‐Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, The Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group. Intravenous magnesium for pediatric sickle cell vaso‐occlusive crisis: Methodological issues of a randomized controlled trial. Pediatr Blood Cance r 2014; 61: 1049 – 1054.
dc.identifier.citedreferenceHolmes JF, Holubkov R, Kuppermann N, Pediatric Emergency Care Applied Research Network (PECARN). Guardian availability in children evaluated in the emergency department for blunt head trauma. Acad Emerg Med 2009; 16: 15 – 20.
dc.identifier.citedreferenceGrap MJ, Munro CL. Subject recruitment in critical care nursing research: A complex task in a complex environment. Heart Lung 2003; 32: 162 – 168.
dc.identifier.citedreferenceDunlop AL, Leroy ZC, Logue KM, Glanz K, Dunlop BW. Pre‐consent education about research processes improved African Americans’ willingness to participate in clinical research. JCE 2011; 64: 872 – 877.
dc.identifier.citedreferenceGlickman SW, Anstrom KJ, Lin L, Chandra A, Laskowitz DT, Woods CW, Freeman DH, Kraft M, Beskow LM, Weinfurt KP, Schulman KA, Cairns CB. Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. Ann Emerg Med 2008; 51: 775 – 780.
dc.identifier.citedreferenceScharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: Understanding mistrust about research participation. J Health Care Poor Underserved 2010; 21: 879 – 897.
dc.identifier.citedreferenceCorbie‐Smith G, Thomas SB, Williams MV, Moody‐Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. JGIM 1999; 14: 537 – 546.
dc.identifier.citedreferenceEl‐Sadr W, Capps L. The challenge of minority recruitment in clinical trials for AIDS. JAMA 1992; 267: 954 – 957.
dc.identifier.citedreferenceByrne G, Heyman R. Patient anxiety in the accident and emergency department. J Clin Nurs 1997; 6: 289 – 295.
dc.identifier.citedreferenceChapman SL, Byas‐Smith MG, Reed BA. Effects of intermediate‐ and long‐term use of opioids on cognition in patients with chronic pain. Clin J Pain 2002; 18: S83 – S90.
dc.identifier.citedreferenceTelen MJ, Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR, Rhee S, Magnani JL, Thackray H. Randomized phase 2 study of GMI‐1070 in SCD: Reduction in time to resolution of vaso‐occlusive events and decreased opioid use. Blood 2015; 125: 2656 – 2664.
dc.identifier.citedreferenceChamberlain JM, Lillis K, Vance C, Brown KM, Fawumi O, Nichols S, Davis CO, Singh T, Baren JM, Pediatric Emergency Care Applied Research Network. Perceived challenges to obtaining informed consent for a time‐sensitive emergency department study of pediatric status epilepticus: results of two focus groups. Acad Emerg Med 2009; 16: 763 – 770.
dc.identifier.citedreferenceDampier CD, Smith WR, Kim HY, Wager CG, Bell, MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol 2011; 86: E70 – E73.
dc.identifier.citedreferenceStyles L, Wager CG, Labotka RJ, Smith‐Whitley K, Thompson AA, Lane PA, McMahon LEC, Miller R, Roseff SD, Iyer RV, Hsu LL, Castro OL, Ataga KI, Onyekwere O, Okam M, Bellevue R, Miller ST, for the Sickle Cell Disease Clinical Research Network (SCDCRN). Refining the value of secretory phospholipase A 2 as a predictor of acute chest syndrome in sickle cell disease: Results of a feasibility study (PROACTIVE). Br J Haematol 2012; 157: 627 – 636.
dc.identifier.citedreferenceDampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith‐Whitley K, Telen MJ, Sickle Cell Disease Clinical Research Network (SCDCRN). Improve trial: A randomized controlled trial of patient‐controlled analgesia for sickle cell painful episodes: Rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials 2013; 10: 319 – 331.
dc.identifier.citedreferencePeters‐Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP, Sickle Cell Disease Clinical Research Network (SCDCRN). Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial. Contemp Clin Trials 2012; 33: 291 – 297.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.